Molecular Biology Enzymes, Kits, and Reagents Market Size and Competitive Analysis by 2028

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, Cloning, and Other), and End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centers, and Academic & Research Institutes)

  • Report Date : Jun 2022
  • Report Code : TIPHE100001119
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 255

The molecular biology enzymes, kits, and reagents market is likely to be valued at US$ 15,715.48 million in 2022 and it is projected to reach US$ 41,104.71 million by 2028; it is expected to grow at a CAGR of 17.8% from 2022 to 2028.

Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during various processes such as polymerase chain reaction (PCR), DNA sequencing, and cell analysis. The growth of the market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases. However, the dearth of skilled professionals hinders the market growth.

The molecular biology enzymes, kits, and reagents market is witnessing substantial growth amid COVID-19 pandemic. The majority of the healthcare research organizations, market players, and academic centers are actively engaged in the research and development activities to develop new vaccines and therapeutic platforms for novel coronavirus that causes COVID-19. This extensive rise in research and development activities is expected to boost the demand for molecular biology kits and reagents, which, in turn, would drive the growth of the molecular biology enzymes, kits, and reagents market in coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Molecular Biology Enzymes, Kits, and Reagents Market: Strategic Insights

molecular-biology-enzymes-kits-reagents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights
Healthy Funding for Genomics Drives Market Growth

Genome sequencing was restricted to the research facilities, a few years back. However, it has now became one of the common techniques in clinical practices. Over the next few years, the healthcare sector is expected to generate genomic data of over 60 million patients. The growing implementation of genomic sequencing into healthcare systems is supported by substantial government investments, totaling over US$ 4 billion in at least 14 countries. The UK has announced the world’s largest genome project as part of 200 million public–private collaboration between charitable organizations and pharmaceutical companies. The country has already developed the world’s largest genome database through the 100,000 Genomes Project. Led by Innovate UK, a part of UK Research and Innovation, the project was initiated to support researchers and industries through funds to combine data and real-world evidence obtained from UK health services as well as to create new products and services for more efficient and early disease diagnosis.

In November 2018, Stilla Technologies, France, announced the completion of a Series A financing round, gathering US$ 18.3 million (EUR 16 million) in funds; the round was led by Illumina Ventures. The company plans to use these funds to commercialization of its Naica digital PCR system and development of clinical applications. Further, in June 2020, Base Genomics, an epigenetics company based in Oxford, England, closed a seed funding round of US$ 11 million (GBP 9 million). In August 2018, Nebula Genomics, a company based in Boston, Massachusetts, along with 10 leading venture capital firms, raised US$ 4.3 million in seed funding. as a part of partnership with Veritas Genetics, a genome sequencing company. The company aims to use these funds to create a trustworthy, secure, and decentralized marketplace for genomic data. In March 2018, SynbiCITE (UK) received grants worth ~US$ 17.6 million (GBP 13 million) and private investments worth US$ 318.5 million (GBP 234 million). The company is made for increasing synbio applications in the UK. The SynbiCITE has supported the synbio at national level for the increase of gene synthesis applications.

In April 2020, MedGenome, a genetic diagnostics, research, and data company headquartered in Bengaluru, India, raised US$ 55 million (~INR 419 crore) in a new round of funding, led by LeapFrog Investments, a global impact investment firm. MedGenome also claims to have built the largest database of South Asian genetic variants in genetic diagnostics in India and research partnerships. It has conducted over 200,000 genomic tests to date by obtaining samples from more than 550 hospitals and 6,000 clinicians across India.

Such continuous funding by the manufacturers and governments in the field of genomics is supporting the molecular biology enzymes, kits, and reagents market growth.

Product-Based Insights

Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020, and the same segment is estimated to register a higher CAGR during the forecast period.

Application-Based Insights

The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. However, the polymerase chain reaction segment is estimated to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020, and the same segment is estimated to register the highest CAGR during the forecast period.

The molecular biology enzymes, kits, and reagents market players are adopting the product launch and expansion strategies to meet changing customer demands worldwide, which allow them to maintain their brand name globally.

Molecular Biology Enzymes Kits and Reagents

Molecular Biology Enzymes, Kits, and Reagents Market Regional Insights

The regional trends and factors influencing the Molecular Biology Enzymes, Kits, and Reagents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Molecular Biology Enzymes, Kits, and Reagents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

molecular-biology-enzymes-kits-reagents-market-global-geography
  • Get the Regional Specific Data for Molecular Biology Enzymes, Kits, and Reagents Market

Molecular Biology Enzymes, Kits, and Reagents Market Report Scope

Report Attribute Details
Market size in 2022 US$ 15.72 Billion
Market Size by 2028 US$ 41.1 Billion
Global CAGR (2022 - 2028) 17.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product
  • Enzymes and Kits & Reagents
By Application
  • Epigenetics
  • Sequencing
  • Synthetic Biology
  • Polymerase Chain Reaction
  • Cloning
By End User
  • Biotechnological & Pharmaceutical Companies
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC
  • Illumina, Inc.
  • Qiagen
  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
  • Merck KGAA
  • Jena Bioscience GmbH
  • Bioline Technologies
  • Promega Corporation

  • Molecular Biology Enzymes, Kits, and Reagents Market Players Density: Understanding Its Impact on Business Dynamics

    The Molecular Biology Enzymes, Kits, and Reagents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Molecular Biology Enzymes, Kits, and Reagents Market are:

    1. THERMO FISHER SCIENTIFIC INC
    2. Illumina, Inc.
    3. Qiagen
    4. Agilent Technologies, Inc.
    5. F. HOFFMANN-LA ROCHE LTD

    Disclaimer: The companies listed above are not ranked in any particular order.


    molecular-biology-enzymes-kits-reagents-market-cagr

    • Get the Molecular Biology Enzymes, Kits, and Reagents Market top key players overview

    Molecular Biology Enzymes, Kits, and Reagents Market – by Product

    • Enzymes
      • Polymerases
      • Ligases
      • Reverse Transcriptases
      • Phosphatases
      • Proteases and Proteinases
      • Restriction Endonuclease
      • Other
    • Kits and Reagents
      • Lyophilisable and air dryable
      • NGS
      • PCR
        • Real-time PCR/ quantitative real-time PCR (qPCR)
        • Reverse transcriptase PCR (RT-PCR)
        • Multiplex PCR
        • Others
    • cDNA synthesis
    • isothermal amplification
    • DNA extraction
    • others

    Molecular Biology Enzymes, Kits, and Reagents Market – by Application

    • Epigenetics
    • Sequencing
    • Synthetic Biology
    • Polymerase Chain Reaction
    • Other

    Molecular Biology Enzymes, Kits, and Reagents Market – by End User

    • Biotechnological and Pharmaceutical Companies
    • Hospitals and Diagnostic Centres
    • Academic and Research Institutes

    Molecular Biology Enzymes, Kits, and Reagents Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South America and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • THERMO FISHER SCIENTIFIC INC
    • Illumina, Inc.
    • Qiagen
    • Agilent Technologies, Inc.
    • F. HOFFMANN-LA ROCHE LTD
    • Merck KGAA
    • Jena Bioscience GmbH
    • Bioline Technologies
    • Promega Corporation
    • Rockland Immunochemicals

    Frequently Asked Questions

    Who are the major players in the molecular biology enzymes, kits, and reagents market?

    The molecular biology enzymes, kits, and reagents market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc amongst others.

    Which segment will lead the molecular biology enzymes, kits, and reagents market?

    Based on product, molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. In 2020, kits & reagents held the largest segment, and moreover, the same segment is expected to grow at the highest CAGR during the forecast period.

    Which application segment will lead the molecular biology enzymes, kits, and reagents market?

    The sequencing segment dominated the global molecular biology enzymes, kits, and reagents market and accounted for the largest revenue of US$ 3,815.02 Mn in 2020.

    What is the regional market scenario in the global molecular biology enzymes, kits, and reagents market?

    Global molecular biology enzymes, kits & reagents market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global molecular biology enzymes, kits & reagents market and is expected to hold its strong foothold in the coming years. The region is expected to witness consistent growth owing to factors such as rapid sequencing technologies, increasing preference for personalized medicine, increasing competition between the market player, high R&D spending to develop new sequencing products, and sophisticated infrastructure.
    The Asia Pacific region is expected to account for the fastest growth in the molecular biology enzymes, kits & reagents market. In India and China, the market is expected to grow rapidly owing to factors such as the rise in the development and research for genomics and the rise in the programs for the genomics are expected to drive the molecular biology enzymes, kits & reagents market in the forecast period. In addition, the initiatives by the government of India for the startups in biotechnology sectors.

    What are molecular enzymes?

    Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during PCR, DNA sequencing, and cell analysis amongst others.

    What are the driving factors for the molecular biology enzymes, kits, and reagents market across the globe?

    The growth of the molecular biology enzymes, kits, and reagents market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Molecular Biology Enzymes, Kits, and Reagents Market

    1. THERMO FISHER SCIENTIFIC INC
    2. Illumina, Inc.
    3. Qiagen
    4. Agilent Technologies, Inc.
    5. F. HOFFMANN-LA ROCHE LTD
    6. Merck KGAA
    7. Jena Bioscience GmbH
    8. Bioline Technologies
    9. Promega Corporation
    10. Rockland Immunochemicals Inc  
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo